18 November 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PULL Incentives: ‘Incentivising a sustainable response to the threat of AMR’

Without adequate incentives it is anticipated that in less than 2 years from now, many AMR SMEs will have disappeared…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

25 March 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PUSH Incentives: ‘Supporting financial investments on R&D to de-risk antimicrobial development!’

The intention of this Memo is to provide different suggestions to help ensure that the R&D funding instruments (e.g. from…

18 November 2019 - BEAM Alliance

New BEAM Alliance Position Paper calls out stakeholders to rapidly provide market-based solutions supporting SME-driven innovation against antimicrobial resistance

The European BEAM Alliance, representing 72 ‘Biotech companies from Europe innovating in AntiMicrobial resistance research’, today released a position paper…

BEAM News
Member News
Events

Latest news of BEAM Alliance

03 December 2019 - BEAM Alliance

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

The aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or…

18 November 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PULL Incentives: ‘Incentivising a sustainable response to the threat of AMR’

Without adequate incentives it is anticipated that in less than 2 years from now, many AMR SMEs will have disappeared…

18 November 2019 - BEAM Alliance

New BEAM Alliance Position Paper calls out stakeholders to rapidly provide market-based solutions supporting SME-driven innovation against antimicrobial resistance

The European BEAM Alliance, representing 72 ‘Biotech companies from Europe innovating in AntiMicrobial resistance research’, today released a position paper…

19 July 2019 - BEAM Alliance

BEAM Alliance: Time to give your feedback on how to characterize antimicrobial activity!

The BEAM Alliance proposed a six-way approach to characterize ATM activity, with the aim of opening new doors in the…

06 June 2019 - BEAM Alliance

Emergency on planet AMR: a vital pipeline to protect

The sooner we come up with practical solutions, the more SMEs (and currently developed products) we can save from vanishing.…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

page 1/3

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

03 December 2019 - Grit42

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

Co-founder and CEO of grit42, Claus Stie Kallesøe, adds, “The COMBINE project is an important milestone in the evolution of…

18 November 2019 - Grit42

Strengthening their commitment to help tackle antimicrobial resistance, grit42 joins the BEAM Alliance

“We’re thrilled to join the BEAM Alliance - the premier European network within the AMR community. As we’re already part…

18 November 2019 - Nabriva Therapeutics GmbH

Nabriva Therapeutics Commends the CDC on the 2019 Antibiotic Resistance Threats Report, Highlighting the Need for New Antibiotics Aligned with Antibiotic Stewardship

“World Antibiotic Awareness Week is November 18-24, 2019, providing an opportune time to engage and encourage clinicians, policy makers, and…

31 October 2019 - Gedea Biotech AB

Gedea: All patients treated in proof of concept study in women with bacterial vaginosis

Annette Säfholm, Gedea Biotech’s CEO comments: “We are delighted to report that we already see promising results when it comes…

29 October 2019 - BioVersys AG

BioVersys Receives CARB-X Award of up to US$ 8.92 Million for development of first-in-class stand-alone anti-virulence small molecule drugs – A paradigm shift in AMR therapy

CARB-X funds BioVersys up to US$ 8.92 million to support the development of first-in-class anti-virulence small molecule drugs that disarm…

23 October 2019 - Alaxia

Alaxia joins EU consortium to combat Drug-Resistant Lung infections

“Alaxia is honored to have been selected to join the iABC project on fighting antimicrobial resistance in patients with lung…

page 1/15

Events

13 July 2020

Curious2020 – Future Insight

In 2020 the Future Insight Prize will be given out in the area of Multi Drug Resistance to enable a…

13 December 2019

JPIAMR Hacking AMR 2019

Finding digital solutions to fight Antimicrobial Resistance is our theme for this special international JPIAMR hackathon. The hackathon aim is…

05 December 2019

Life Sciences Series #1

The Ark Life Science Series #1 provides an excellent opportunity to exchange with representatives from all relevant sectors (pharmaceutical companies,…

26 November 2019

REVIVE Webinar: Innovation in point-of-care diagnostics for sepsis and bloodstream infections

In this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give…

13 November 2019

Matchmaking Symposium ‘Emerging Antimicrobials and Diagnostics in AMR 2019’

The event provides an excellent podium for emerging Antimicrobials and Diagnostics as well as an exciting program including orchestrated matchmakings,…

11 November 2019

BIO-Europe, 25th Annual International Partnering Conference

Celebrating 25 years of facilitating partnerships that drive life science dealmaking!

07 November 2019

World Anti-Microbial Resistance Congress

The conference gathers global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on seven topic…

07 November 2019

REVIVE webinar: Converting Gram-positive-only compounds into broad-spectrum antibiotics

This webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail…

19 October 2019

4th International Course on Antibiotics and Resistance (ICARe)

The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is…

page 1/4